Vadodara, India

Surendra B Bhatt

This inventor holds 1 USPTO granted patent. Top assignee: Alembic Limited. Active years: 2007.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Surendra B Bhatt: Innovator in Pharmaceutical Chemistry

Introduction

Surendra B Bhatt is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important compounds.

Latest Patents

Surendra B Bhatt holds a patent for the "Process for the preparation of 2-[(diphenylmethyl) thio] acetamide." This innovative process involves reacting 2-[(diphenylmethyl)thio]acetic acid with alcohols in the presence of a catalytic amount of inorganic or organic acid at reflux temperature. The resulting ester is then reacted with ammonia to yield 2-[(diphenylmethyl)thio]acetamide. This compound serves as an intermediate for the preparation of Modafinil, a central nervous system stimulant used in the treatment of narcolepsy. If desired, the produced 2-[(diphenylmethyl)thioacetamide can be further reacted with hydrogen peroxide to produce Modafinil.

Career Highlights

Surendra B Bhatt is associated with Alembic Limited, a prominent pharmaceutical company. His work has contributed to advancements in drug formulation and synthesis, showcasing his expertise in the field.

Collaborations

He has collaborated with notable colleagues, including Jiten R Patel and Dinesh Panchasara, to further enhance the research and development efforts within his organization.

Conclusion

Surendra B Bhatt's innovative work in pharmaceutical chemistry, particularly in the synthesis of compounds like Modafinil, highlights his significant contributions to the industry. His patent and collaborations reflect his commitment to advancing medical science and improving treatment options.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…